Article

GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3…

Journal of Immunology Research · 2023 · Jing Ning, author Jianqiao Ding, author Shu Wang, author Youhong Jiang, author Daqing Wang, author Shenyi Jiang, author Xiaofeng Yang, Academic Editor

Key facts

Title GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells
First author Jing Ning, author Jianqiao Ding, author Shu Wang, author Youhong Jiang, author Daqing Wang, author Shenyi Jiang, author Xiaofeng Yang, Academic Editor
Journal Journal of Immunology Research
Published May 26, 2023
DOI 10.1155/2023/5532617
Product codes mentioned MVU

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature